Evaluating the Safety of Prenatal RSVpreF Vaccination: Implications for Obstetric and Neonatal Outcomes
A large-scale VSD study found that prenatal vaccination with bivalent prefusion F RSV vaccine is generally safe, showing no increased risk for preterm birth, stillbirth, or small-for-gestational-age births but a slight increase in hypertensive disorders of pregnancy.